Autoimmunity in dilated cardiomyopathy

Dilated eardiomyopathy as defined by the WHO/ISFC task force includes idiopathic dilated heart muscle diseases as well as secondary forms, such as postmyoearditic dilated heart muscle disease, genetically inherited or predisposed forms, and forms of metabolic/toxic etiology. In isehemic cardiomyopathy, impaired function results from the remodeling process in the presence of coronary artery disease when viable myocardium is still present [1]. In this article, the focus is on forms of dilated cardiomyopathy (DCM) when the etiology and pathogenesis point to an inflammatory origin of the dilated heart muscle disease. The term acute~active myocarditis is used according to the Dallas criteria, whereas chronic inflammatory heart muscle disease is assumed if diagnostic criteria in the definition of Maisch are present [2,3]. Figure 1 shows the diagnostic matrix of cardiomyopathies, including genetic, viral, inflammatory, and postinflammatory forms.

[1]  M. Herzum,et al.  Cytomegalovirus associated inflammatory heart muscle disease. , 1993, Scandinavian journal of infectious diseases. Supplementum.

[2]  J. Mason,et al.  Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. , 1980, The American journal of cardiology.

[3]  P. Lodge,et al.  Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. , 1984, The American journal of pathology.

[4]  M. Herzum,et al.  Four years of experience in endomyocardial biopsy —An immunohistologic approach , 2005, Heart and Vessels.

[5]  I. Palacios,et al.  Culture and characterization of lymphocytic infiltrates from endomyocardial biopsies of patients with idiopathic myocarditis , 1987 .

[6]  Jeffrey L. Anderson,et al.  Immunofluorescence Microscopy in the Diagnosis and Follow-up of Patients Suspected of Having Inflammatory Heart Disease , 1988 .

[7]  B. Maisch,et al.  Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. , 1983, The American journal of cardiology.

[8]  B. Maisch,et al.  Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. , 1982, Clinical and experimental immunology.

[9]  Woodruff Jf Viral myocarditis. A review. , 1980 .

[10]  W. Abelmann,et al.  Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis. , 1990, Circulation.

[11]  G. Wallukat,et al.  Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. , 1994, Circulation.

[12]  K. Beisel,et al.  Postinfectious Autoimmunity: Two Distinct Phases of Coxsackievirus B3‐Induced Myocarditis a , 1986, Annals of the New York Academy of Sciences.

[13]  F. Camerini,et al.  Immunosuppressive therapy for myocarditis. , 1995, The New England journal of medicine.

[14]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[15]  F. Lottspeich,et al.  Characterization of relevant membrane antigens by two-dimensional immunoblot and n-terminal sequence analysis in patients with myocarditis. , 1995, European heart journal.

[16]  M. Herzum,et al.  Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. , 1995, European heart journal.

[17]  G. Mudge,et al.  Results of heart transplantation for active lymphocytic myocarditis. , 1990, The Journal of heart transplantation.

[18]  P. Lodge,et al.  Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. , 1987, The American journal of pathology.

[19]  E. Borda,et al.  T lymphocytes from T. cruzi-infected mice alter heart contractility: participation of arachidonic acid metabolites. , 1992, Journal of molecular and cellular cardiology.

[20]  J. Towbin,et al.  Acute Myocarditis : Rapid Diagnosis by PCR in Children 331 TABLE 1 . Dallas Criteria * General definition : Myocardial cell injury with degeneration or necrosis with inflammatory infiltrate not due to ischemia , 2005 .

[21]  B. Maisch Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury , 2004, Springer Seminars in Immunopathology.

[22]  H. Jomaa,et al.  Left ventricular hemodynamic parameters in the course of acute experimental coxsackievirus B 3 myocarditis. , 1995, Journal of molecular and cellular cardiology.

[23]  I. Goldenberg,et al.  Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. , 1989, Circulation research.

[24]  K. Beisel,et al.  Cardiac myosin induces myocarditis in genetically predisposed mice. , 1987, Journal of immunology.

[25]  M. Morad,et al.  Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. , 1988, The American journal of physiology.

[26]  J. Carlquist,et al.  HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. , 1991, Circulation.

[27]  H. Schultheiss,et al.  Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. , 1985, Journal of molecular and cellular cardiology.

[28]  B. Maisch,et al.  Does CMV infection play a role in myocarditis? New aspects from in-situ hybridization. , 1991, European heart journal.

[29]  C. Hengstenberg,et al.  Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies? , 1991, Basic research in cardiology.

[30]  K. Beisel,et al.  Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. , 1986, Journal of immunology.

[31]  B. Maisch,et al.  Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. , 1984, Clinical and experimental immunology.

[32]  S. Huber,et al.  Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice. , 1983, Advances in experimental medicine and biology.

[33]  K. Beisel,et al.  Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. , 1987, Clinical and experimental immunology.

[34]  M. Herzum,et al.  Circulating immune complexes in perimyocarditis and infective endocarditis , 1987 .

[35]  S. Boyden,et al.  Natural antibodies and the immune response. , 1966, Advances in immunology.

[36]  H. Schultheiss,et al.  Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. , 1989, Circulation research.

[37]  J E Parrillo,et al.  A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.

[38]  M. Herzum,et al.  Coxsackievirus B3 infection leads to cell death of cardiac myocytes. , 1994, Journal of molecular and cellular cardiology.

[39]  A. Matsumori,et al.  Therapeutic Effect of Anti‐Tumor Necrosis Factor‐α Antibody on the Murine Model of Viral Myocarditis Induced by Encephalomyocarditis Virus , 1994, Circulation.

[40]  C. Hengstenberg,et al.  Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial. , 1994, Postgraduate medical journal.

[41]  K. Beisel,et al.  Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens. , 1987, Clinical immunology and immunopathology.

[42]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.

[43]  C. Hengstenberg,et al.  The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). , 1995, European heart journal.

[44]  B. Maisch,et al.  Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis. , 1993, Clinical immunology and immunopathology.

[45]  N. Bowles,et al.  DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.

[46]  J. Mcanulty,et al.  Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. , 1985, Journal of the American College of Cardiology.

[47]  P. Hofschneider,et al.  Viral heart disease , 2004, Springer Seminars in Immunopathology.

[48]  B. Maisch,et al.  Assessment of antibody mediated cytolysis of adult cardiocytes isolated by centrifugation in a continuous gradient of Percoll in patients with acute myocarditis. , 1981, Journal of immunological methods.

[49]  J. Robinson,et al.  The effects of cyclosporine on acute murine Coxsackie B3 myocarditis. , 1986, Circulation.

[50]  B. Maisch,et al.  Immune reactions in tuberculous and chronic constrictive pericarditis. Clinical data and diagnostic significance of antimyocardial antibodies. , 1982, The American journal of cardiology.

[51]  B. Maisch,et al.  Cytomegalovirus-associated heart muscle disease. , 1995, European heart journal.

[52]  N. Fowler,et al.  Immunologic findings in idiopathic cardiomyopathy: a prospective serial study. , 1973, American heart journal.

[53]  B. McManus,et al.  A molecular and serologic evaluation of enteroviral involvement in human myocarditis. , 1990, Journal of molecular and cellular cardiology.

[54]  B. Maisch,et al.  Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. , 1993, Circulation.

[55]  G. Schreiner,et al.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Maisch Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. , 1986, Basic research in cardiology.

[57]  Craven Pc Interaction of ketoconazole with rifampin and isoniazid. , 1985 .

[58]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[59]  B. Maisch,et al.  The use of endomyocardial biopsy in heart failure. , 1988, European heart journal.

[60]  P. Hofschneider,et al.  Effect of Interferon on the Replication of Coxsackie B3 Virus in Cultured Human Fetal Heart Cells , 1984 .

[61]  A. Heim,et al.  Subclassification of dilated cardiomyopathy and interferon treatment. , 1995, European heart journal.